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Background: Protein Ser/Thr Phosphatase PPP1CC2 is an alternatively spliced isoform of PPP1C that is highly
enriched in testis and selectively expressed in sperm. Addition of the phosphatase inhibitor toxins okadaic acid or
calyculin A to caput and caudal sperm triggers and stimulates motility, respectively. Thus, the endogenous
mechanisms of phosphatase inhibition are fundamental for controlling sperm function and should be characterized.
Preliminary results have shown a protein phosphatase inhibitor activity resembling PPP1R2 in bovine and primate
spermatozoa.
Results: Here we show conclusively, for the first time, that PPP1R2 is present in sperm. In addition, we have also
identified a novel protein, PPP1R2P3. The latter was previously thought to be an intron-less pseudogene. We show
that the protein corresponding to the pseudogene is expressed. It has PPP1 inhibitory potency similar to PPP1R2.
The potential phosphosites in PPP1R2 are substituted by non-phosphorylable residues, T73P and S87R, in PPP1R2P3.
We also confirm that PPP1R2/PPP1R2P3 are phosphorylated at Ser121 and Ser122, and report a novel
phosphorylation site, Ser127. Subfractionation of sperm structures show that PPP1CC2, PPP1R2/PPP1R2P3 are
located in the head and tail structures.
Conclusions: The conclusive identification and localization of sperm PPP1R2 and PPP1R2P3 lays the basis for future
studies on their roles in acrosome reaction, sperm motility and hyperactivation. An intriguing possibility is that a
switch in PPP1CC2 inhibitory subunits could be the trigger for sperm motility in the epididymis and/or sperm
hyperactivation in the female reproductive tract.
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Spermatozoa are specialized cells that are highly com-
partmentalized, transcriptionally inactive and unable to
synthesize new proteins. Protein phosphorylation is a
post-translational mechanism that plays a crucial role
in sperm physiology, controlling motility, capacitation,
hyperactivated motility and the acrosome reaction [1,2].
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distribution, and reproduction in any mediuminfertility [2]. The biochemical mechanisms essential for
the development of motility are still far from under-
stood, however, serine/threonine protein phosphatase 1
(PPP1) and glycogen synthase kinase 3 (GSK3), have
been recognized as components of the regulatory mech-
anism [3-5]. Three separate genes (α/A, β/δ/B and γ/C)
encode the catalytic subunit of PPP1 (PPP1C). PPP1CC
undergoes alternative splicing, giving rise to a ubiquitous
isoform PPP1CC1 and a testis-enriched and sperm
specific-isoform, PPP1CC2 [3,5]. PPP1CC2 is the only
PPP1 isoform highly enriched in bovine, rhesus monkey
and human sperm [3,5]. The phosphatase is distributed
along the entire flagellum, including the mid-piece, con-
sistent with a role in sperm motility, and also in the pos-
terior and equatorial regions of the head, suggesting ad Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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that PPP1C had a two-fold higher activity in immotile
bovine caput epididymal sperm compared to mature
motile caudal sperm is consistent with it being directly
involved in sperm motility [3,5]. Moreover, inhibition of
PPP1CC2 activity by the toxins okadaic acid or calyculin
A induced and stimulated motility in caput and caudal
sperm, respectively [3,5]. Homozygous knockout mice
for Ppp1cc gene (a deletion of both isoforms) lead to
sterility of male but not female mice. The sterility
resulted from a combination of gross structural defects in
spermatids that cause apoptosis and lack of spermiation
[8,9]. The evolutionary conservation and the importance of
Ser/Thr phosphatases in regulating flagellar motility, is
highlighted by the involvement of a PPP1 homolog in the
regulation of rooster sperm motility [10] and by the
involvement of a Ser/Thr phosphatase in the regulation of
microtubule sliding velocity in Paramecium and Chlamydo-
monas [11,12].
Regulation of PPP1 catalytic activity is mediated via bind-
ing to specific regulatory subunits, the PPP1 interacting
proteins [13-15]. The extensive diversity of such interacting
proteins and their tissue specificity makes them potential
pharmacological targets [14]. To date, studies have shown
that sperm do not appear to contain PPP1R1 (inhibitor-1,
I1), whose activity is controlled by protein kinase A phos-
phorylation [3,5,16]. However, a PPP1R2-like activity seems
to be present in sperm due to its sensitivity to GSK3 phos-
phorylation [3,5]. PPP1 and PPP1R2 are known to form a
stable, catalytically inactive heterodimer, also known as
MgATP-dependent phosphatase [17]. PPP1R2 can also
bind and regulate PPP1C already complexed to other regu-
latory subunits [17]. Phosphorylation of PPP1R2 at Thr73
by GSK3 releases the inhibition and the phosphatase
becomes active [18]. Immotile caput sperm contained six-
fold higher GSK3 activity than motile caudal sperm [3,5].
The presence and activity of GSK3 in sperm has been
further characterized, emphasizing its role in sperm motility
regulation [19,20].
Recent experiments have demonstrated that sperm
also contains the homologue of the yeast PPP1 binding
protein, PPP1R7 (Sds22) and that the complex with
PPP1CC2 is catalytically inactive [6]. Finally, a potent
heat-stable inhibitor was identified as the orthologue of
the mouse t complex testis-expressed gene Tctex5, also
known as PPP1R11 (inhibitor 3, I3) [21]. The heat stabil-
ity of these inhibitors is important for facilitating the
purification, although no other function was found so
far for this property. It was also shown that both inhibi-
tors, PPP1R7 and PPP1R11, form a catalytically inactive
multi-complex with PPP1CC2 in sperm [22].
Despite these findings whether sperm contain PPP1R2
remains undetermined. The purpose of this study was to
determine if PPP1R2 was present in spermatozoa. Weshow here, for the first time, the presence and localization
of PPP1R2 in human spermatozoa. Furthermore, we
demonstrate the presence of PPP1R2P3, a new isoform of
PPP1R2. The gene corresponding to PPP1R2P3 was previ-
ously designated as an intron-less pseudogene [23]. Our
studies raise the intriguing possibility that the interplay be-
tween PPP1CC2/PPP1R2 and PPP1CC2/PPP1R2P3 could
operate to regulate human sperm function.
Results and discussion
Identification of PPP1R2P3 - a novel PPP1R2 isoform
in testis
The catalytic subunit isoforms PPP1CC1 and PPP1CC2
were used as baits to screen a human testis cDNA li-
brary by yeast two-hybrid [2,15]. From the PPP1CC1
screening, 120 positive clones were recovered, one of
which encoded the complete sequence of a novel isoform
of the regulatory protein known as PPP1R2 or inhibitor 2
(I2). This novel clone is located on chromosome 5, aligns
to the sequence ID:NR002168 and is classified as PPP1R2
pseudogene 3 (PPP1R2P3). While PPP1R2 is present on
chromosome 3 and is encoded by 5 exons, PPP1R2P3 is an
intronless gene and therefore was designated as a probable
pseudogene by both NCBI and Ensembl databases. This
clone has been deposited in the GenBank database under
the ID:JF438008.1 [2,15]. The PPP1R2P3 mRNA is also
present in human testis cDNA library repository of the
Mammalian Gene Collection (MGC) program (nucleotide
ID: BC066922; protein ID: Q6NXS1) [24]. By searching
Unigene (NCBI) for PPP1R2P3 specific expressed sequence
tags (ESTs) 15 ESTs were obtained, of which 14 are from
testis. These ESTs are specific for this pseudogene and
cover close to 65% of the PPP1R2P3 nucleotide sequence
including the CDS. Taken together, our results, the ESTs,
and the MGC results [24], support the proposal that
PPP1R2P3 is not a pseudogene and is indeed expressed in
testis. Furthermore, by blast search we only found orthologs
of this pseudogene in primate’s assembly genomes.
PPP1R2P3 has only 16 nucleotide substitutions (92.2%,
identity) relative to PPP1R2, which correspond to 9
amino acid changes (95%, identity) in the translated
sequence. Comparing the PPP1R2P3 protein sequence
with that of the PPP1R2 using ClustalW2, we found that
all the PPP1C binding regions are maintained (Figure 1).
However, there are important differences between
PPP1R2 and PPP1R2P3, in that the phosphorylation sites
of the latter, for GSK3 (Thr73) and CK2 kinase (Ser87),
appear as Pro and Arg, respectively (Figure 1).
PPP1R2P3 interacts and inhibits PPP1C
To validate the yeast two-hybrid result we re-confirmed the
PPP1R2P3 interaction with different PPP1C isoforms. The
sequential yeast co-transformation, showed the interaction
of PPP1R2P3 with PPP1CA, PPP1CC1 and PPP1CC2 and
Figure 1 ClustalW2 alignment of PPP1R2 and PPP1R2P3. Protein sequences for PPP1R2 and PPP1R2P3 were obtained from Uniprot database.
Sequences were submitted to a ClustalW2 alignment. Relevant motifs/regions for PPP1R2/PPP1R2P3 binding to PPP1C are shown in open boxes.
Important phosphorylation sites are indicated with black arrows above the residues and with the respective known kinase. * represent high
conservation, : and . represent low conservation in which the substituted residue has respectively more and less similar properties. Black
horizontal bars below the protein sequences show the coverage of the peptides obtained by mass spectrometry. Black horizontal dash bar
indicates the peptide that allowed for the distinction between PPP1R2P3 from PPP1R2. Black horizontal square dot bar indicates the peptide that
allowed distinguishing PPP1R2.
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(Figure 2A). The apparent relative lack of specificity toward
the PPP1C isoforms may arise given that in yeast co-
transformation the interaction is forced and happens inside
the nucleus. In vivo, the PPP1C isoforms have different
tissue/cellular and subcellular localizations that would in-
fluence the PPP1R2P3 interaction. In order to compare the
binding of PPP1R2 and PPP1R2P3 to PPP1CC isoforms,
and demonstrate the interaction as direct, a blot overlay
was performed (Figure 2B). A blot containing the same
amount of commercial PPP1R2 or His-PPP1R2P3 was
incubated with PPP1CC1 or PPP1CC2 and the interaction
detected using the CBC3C and the CBC502 antibodies,
respectively (Figure 2B). The binding of PPP1R2P3 to both
PPP1CC isoforms was confirmed and the binding was simi-
lar to that of PPP1R2.
Since PPP1R2 is a potent heat-stable inhibitor of PPP1
in the nanomolar range [25], we decided to determine
whether PPP1R2P3 is heat-stable, if it exhibited PPP1
inhibitory activity, and if so, what was the potency com-
pared to that of PPP1R2. We determined the IC50
values of recombinant His-PPP1R2P3 for the PPP1CC
isoforms using the standard phosphorylase phosphat-
ase assay [26]. Results showed that PPP1R2P3 is a
potent heat-stable inhibitor of PPP1C with a dose-
response curve similar to the commercial PPP1R2
(Figure 3A) and IC50 values in the subnanomolar
range (Figure 3B, PPP1CC1, 0.73 ± 0.10 nM and
PPP1CC2, 0.09 ± 0.08 nM).GSK3 does not phosphorylate PPP1R2P3 in vitro
Phosphorylation of PPP1R2 at Thr73 (in rabbit) by
GSK3, relieves the inhibition of PPP1C and the complex
PPP1C/PPP1R2 becomes active [18]. Also, phosphoryl-
ation by CK2 at the serines 87, 121 and 122 enhances
Thr73 phosphorylation [27,28]. The absence of the
GSK3 phosphorylation site, Thr73, and of the CK2 phos-
phorylation site, Ser87, in PPP1R2P3 led us to test the
phosphorylation of PPP1R2P3 by these kinases. PPP1R2
and PPP1R2P3 were incubated in parallel reactions with
GSK3, or CK2, or both, in the presence of 32P-ATP.
PPP1R2 is known to be a poor substrate for GSK3 alone
in vitro, but synergistic phosphorylation can be observed
if phosphorylated by CK2 plus GSK3 [28]. In our hands
this occurred with recombinant PPP1R2 (Figure 4,
first panel). However, under the same conditions, no
PPP1R2P3 phosphorylation by GSK3 was detected and
the phosphorylation in the presence of both kinases was
the same as with CK2 alone (Figure 4, second panel).
The results indicate that there is no site for GSK3 phos-
phorylation in PPP1R2P3 and that CK2 is still able to
phosphorylate but in other residue rather than Ser87.
PPP1R2 and PPP1R2P3 are present in human ejaculated
sperm
Based on previous biochemical studies it was suggested
that sperm PPP1CC2 is regulated by a PPP1R2-like
activity [3,5]. However, there was no definitive evidence
for the presence of PPP1R2 in spermatozoa. Efforts to
Figure 3 PPP1R2 and PPP1R2P3 inhibit PPP1CC. (A), Graphical representation of PPP1CC1 and PPP1CC2 inhibition curves by commercial
PPP1R2 and His-PPP1R2P3, using phosphorylase a as substrate. (B), Table showing the comparison of PPP1CC isoforms IC50s by PPP1R2 and
PPP1R2P3 using the phosphorylase phosphatase assay. a The values are expressed as the mean ± S.E.M. of at least three independent
experiments.
Figure 2 Interaction of PPP1R2P3 with different PPP1 isoforms. (A), Sequential transformation of yeast AH109 with bait plasmid (pAS2-
PPP1CA, pAS2-PPP1CC1, pAS2-PPP1CC2, or pAS2-PPP1CC2end) and the prey plasmid pACT2-PPP1R2P3. pAS2-PPP1CC2end is the unique
C-terminal tail of PPP1CC2 produced by alternative splicing of the PPP1CC gene. For negative and positive controls pAS2-1/pACT-2 and pVA3-1/pTD1-1
vectors were used, respectively (B), Overlay assay of PPP1R2 and PPP1R2P3. Commercial PPP1R2 and His-PPP1R2P3 were separated by SDS-PAGE,
transferred to nitrocellulose and overlaid with recombinant PPP1CC1 or PPP1CC2, as indicated. Western blotting was performed with the respective
specific antibodies.
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Figure 4 Comparison of PPP1R2 and PPPR2P3 phosphorylation
by GSK3 and CK2. Recombinant PPP1R2 and PPP1R2P3 were
incubated in kinase buffer with reactive ATP (0); or in the presence
of GSK3β kinase (G), CK2 kinase (C) or both kinases (G/C), for 90 min
at 30oC. Protein phosphorylation was detected by autoradiography
(32P) following SDS-PAGE. Immunoreactivity detected with a specific
sheep anti-PPP1R2 antibody is shown for comparative purposes.
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have proven to be difficult because of the low amount of
protein in soluble extracts and the quality of the avail-
able antibodies. PPP1R2 is an intrinsically unstructured
protein (IUP) with a high proportion of charged and
hydrophilic residues versus few hydrophobic residues
[29]. Proteins such as PPP1R2 (predicted, 23 kDa), will
migrate in SDS-PAGE at a position corresponding to a
higher molecular mass than predicted by the primary se-
quence (i.e. 32 kDa) [30,31]. PPP1R2P3 has the same
predicted molecular mass of PPP1R2 and in SDS-PAGE
migrated at the same position of 32 kDa (Figure 2B). To
deal with the low abundance and taking advantage of
the fact that PPP1R2 is heat-stable, protein precipitation
was used to concentrate the samples from heat-treated
extracts [32]. So far only one report showed successful
identification of PPP1R2 in heat-stable extracts of bull testis
and mouse testis and sperm using a PPP1R2 antibody
(rabbit anti-PPP1R2, see Methods) raised in rabbit againstFigure 5 PPP1R2/PPP1R2P3 are present in human testis and ejaculate
(50 μg) of PPP1R2/PPP1R2P3 and PPP1CC isoforms was performed using sh
SDS. β-Tubulin was used as loading control. (B), PPP1R2/PPP1R2P3 was imm
anti-PPP1R2 antibody followed by Western blotting with the same antibod
(soluble fraction) were used as controls. PPP1R2 was immunoprecipitated uan affinity-purified peptide (135REKKRQFEMKRKLH148
from the mouse sequence) [33].
We used a sheep polyclonal anti-PPP1R2 antibody, raised
against purified rabbit PPP1R2 as immunogen to detect
PPP1R2/PPP1R2P3 as a band around the expected size
(32 kDa) in testis and sperm extracts (Figure 5A) [34]. To
demonstrate the presence of PPP1CC in the same extracts,
an antibody against the C-terminus of PPP1CC was used
(CBC3C). We detected two bands in testis that corre-
spond to PPP1CC1 and PPP1CC2, while only one band,
PPP1CC2, was detected in sperm, as expected [3,5]. More-
over, since PPP1R2 and PPP1R2P3 are heat-stable inhibi-
tors, we heated RIPA extracts by boiling. Western blotting
revealed a band corresponding to PPP1R2/PPP1R2P3 at
the expected size of 32 kDa (Figure 5B, second lane). To
unequivocally demonstrate the existence of PPP1R2 and
the new PPP1R2P3 isoform in human sperm we performed
an immunoprecipitation of PPP1R2/PPP1R2P3 from five
independent human ejaculated sperm samples (using
anti-PPP1R2 antibodies (four using the sheep anti-PPP1R2
and one using the rabbit anti-PPP1R2) followed by mass
spectrometry analysis. Immunoprecipitation was performed
using heat-stable extracts of human ejaculates. We
immunoprecipitated sufficient amounts of PPP1R2/
PPP1R2P3 for detection of their peptides by mass
spectrometry (Table 1). Using the Orbitrap Velos mass
spectrometer we identified 41 unique MS/MS spectra
corresponding to 11 different peptides of PPP1R2/
PPP1R2P3. From these, 5 MS/MS spectra correspond
to 2 peptides that match uniquely with PPP1R2, 3 MS/
MS spectra correspond to a peptide that matches
uniquely to PPP1R2P3 and the remaining correspond
to common sequences (Table 1 and Figure 1). Thed sperm. (A), A Western blot of human testis and sperm screening
eep anti-PPP1R2 and CBC3C antibodies. Extracts were prepared in 1%
unoprecipitated from a human sperm heat-stable extract with sheep
y. Recombinant His-PPP1R2P3 (50ηg) and sperm lysate before boiling
sing dynabeads protein G. IP, immunoprecipitation.
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57% for PPP1R2P3. The mascot scores for each
protein were near 600 (additionally, spectra were
manually evaluated). This is the first report of PPP1R2
and PPP1R2P3 recovery from multiple extracts of
human sperm, using two different antibodies.
Mass spectrometry data of the same immunoprecipi-
tates showed that PPP1CC2 was also present. Five pep-
tides out of 10 MS/MS spectra were identified, that
matched PPP1CC2 with 15% coverage and a protein
MASCOT score higher than 200 (manually evaluated). The
results show that PPP1CC2 binds to PPP1R2/PPP1R2P3 in
human spermatozoa (Table 1).Table 1 Peptides identified by Orbitrap Velos mass spectrom
after immunoprecipitation of human sperm samples with she
isoelectric point
Protein name Uniprot ID MW (Da)
PPP1R2 IPP2_HUMAN 23.015
Peptide Range (start-end
K.WDEMNILATYHPADKDYGLMK.I 47–67
K.TSTTSSMVASAEQPRGNVDEELSK.K 19–42
Protein Name Uniprot ID MW (Da)
PPP1R2P3 IPP2M_HUMAN 23.048
Peptide Range (start-end
K.WDEINILATYHPADK.G 47–61
Protein Name MW (Da)
Common to both PPP1R2 and PPP1R2P3
Peptide Range (start-end
R.KLAAAEGLEPK.Y 103–113
R.IQEQESSGEEDSDLSPEER.E 116–134
K.LAAAEGLEPK.Y 104–113
K.LHYNEGLNIK.L 146–155
R.KLHYNEGLNIK.L 145–155
K.LHYNEGLNIKLAR.Q 146–158
R.IQEQESSGEEDSDLSPEEREK.K 116–136
K.DLHDDDEDEEMLETADGESMNTEESNQGSTPSDQQQNK.L 164–201
K.YRIQEQESSGEEDSDLSPEER.E 114–134
K.LAAAEGLEPKYR.I 104–115
K.TSTTSSMVASAEQPR.G 19–33
Protein Name Uniprot ID MW (Da)
PPP1CC2 PP1G_HUMAN 38.518
Peptide Range (start-end
R.VASGLNPSIQK.A 315–325
R.GVSFTFGAEVVAK.F 222–234
K.NVQLQENEIR.G 27–36
K.YPENFFLLR.G 114–122
K.LNIDSIIQR.L 7–15In extracts from ejaculated sperm, three independent
peptides show post-translational modifications, identified
as phosphorylation at Ser121, Ser122 and Ser127.
However, they could not be assigned to either PPP1R2
or PPP1R2P3, given that both proteins are identical in
that region. To our knowledge, this is the first time that
phosphorylation of Ser127 has been reported for
PPP1R2/PPP1R2P3. Tyrosine or threonine phosphoryla-
tions were not detected. The peptides obtained with
phosphorylations correspond to only 7% of the total
number of obtained peptides, strongly supporting the
fact that PPP1R2/PPP1R2P3 are predominantly not
phosphorylated.etry for PPP1R2, PPP1R2P3 or both and for PPP1CC2,
ep or rabbit anti-PPP1R2 antibodies. aa, amino acids; pI,
pI Protein size (aa) Coverage Mascot score
4.64 205 22.0% 74.12
) Number of spectra m/z meas. z Mascot score
3 848.39 3 47.40
2 847.40 3 26.72
pI Protein size (aa) Coverage Mascot score
4.82 205 7.3% 48.95
) Number of spectra m/z meas. z Mascot score
3 595.96 3 48.95
pI Protein size (aa) Coverage Mascot score
49.3% 546.34
) Number of spectra m/z meas. z Mascot score
7 563.83 2 70.38
5 1082.46 2 117.82
5 499.78 2 63.21
4 400.88 3 53.17
4 664.87 2 51.25
2 514.29 3 23.57
2 807.69 3 59.32
1 1434.23 3 30.63
1 828.70 3 11.42
1 439.91 3 15.97
1 784.86 2 49.60
pI Protein size (aa) Coverage Mascot score
5.78 337 15% 252.57
) Number of spectra m/z meas. z Mascot score
5 557.32 2 54.76
2 656.35 2 72.94
2 621.83 2 42.11
1 599.82 2 39.6
1 536.31 2 43.16
Figure 7 PPP1R2/PPP1R2P3 are present in human testis and
sperm extracts. (A), PPP1R2/PPP1R2P3 and PPP1CC2 presence in
testis and in the RIPA supernatant (soluble fraction) and pellet
(insoluble fraction) of sperm lysates, was analyzed using sheep anti-
PPP1R2 and rabbit anti-PPP1CC2 antibodies. 100 μg of both fractions
were loaded in a SDS-PAGE gel. Acetylated α-tubulin was used as a
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Immunocytochemistry was used to study the subcellular
localization of PPP1R2 and PPP1R2P3 and their
co-localization with PPP1CC2 in mature human sperm-
atozoa. Experiments were performed using sheep anti-
PPP1R2 (detects PPP1R2 and PPP1R2P3) and CBC502
antibodies (Figure 6). Results showed that PPP1R2 and
PPP1R2P3 are present along the flagellum, in the mid-
piece, principal piece, except the end-piece, and also in
the head, more specifically in the equatorial and post-
acrosomal regions (Figure 6B). PPP1CC2 localization is
similar, co-localizing to the same regions as seen with
PPP1R2. A negative control using only secondary anti-
bodies showed that the staining was specific (Figure 6A).
The PPP1CC2 localization corroborated a previous re-
port and the localization is consistent with a role for
PPP1 in sperm forward and hyperactivated motility and
possibly in the acrosome reaction [3-5,7,35]. To support
the immunolocalization data, RIPA soluble extracts and
insoluble fractions were resolved by SDS-PAGE and
immunoblotted (Figure 7A). The results showed that
PPP1R2 and PPP1R2P3 were mainly present in the
soluble extracts. Although RIPA lysis buffer is a stringent
buffer we still detected some PPP1R2 protein in the in-
soluble fraction. In contrast, PPP1CC2 is present in both
fractions but more abundantly in the insoluble fraction.
These results are consistent with PPP1CC2 being tightly
attached to the axoneme.Figure 6 Co-localization of PPP1CC2 and PPP1R2/PPP1R2P3 in
morphologically normal and abnormal spermatozoa. Human
spermatozoa were labeled with rabbit anti-PPP1CC2 and sheep anti-
PPP1R2 antibodies, and specific secondary antibodies conjugated
with Texas-Red and FITC fluorophores, respectively. (A), Negative
control using only the fluorescence labeled secondary antibodies.
(B), Spermatozoa with rabbit anti-PPP1CC2 and sheep anti-PPP1R2
antibodies. Phase contrast (PH). Scale bar = 20 μm.
loading control. (B), A human sperm sample (2 × 108 sperm cells)
was sonicated to disrupt head and tail bond, and subjected to a
sucrose gradient. Both pools were verified by phase contrast (PH).
100 μg of both fractions were loaded in a SDS-PAGE gel. After
transfer, the blot was probed with sheep anti-PPP1R2 and rabbit
anti-PPP1CC2 antibodies. Acetylated α-tubulin was used as a
loading control.Furthermore, tail and head preparations were also
obtained using a sucrose gradient. In this separation
although heads are kept intact, tails are demembranated
and only the axoneme structure is maintained, thus all
soluble proteins present in the tail are removed. The results
clearly demonstrate that PPP1R2 and PPP1R2P3, as well as
PPP1CC2, are present in the spermatozoa tail and head
and in similar amounts (Figure 7B).
Phosphorylation of PPP1R2/PPP1R2P3 in human sperm
Western blotting of human sperm heat-treated extracts
revealed, depending on the samples, two bands migrat-
ing slower than the purified PPP1R2 and PPP1R2P3
(Figure 8A). To investigate the nature of those bands,
human sperm heat-treated extracts were resolved by 2D-
PAGE, revealing three isolated spots of different molecu-
lar mass and pI, suggesting the existence of different
phosphorylated forms of PPP1R2 and PPP1R2P3
(Figure 8B, arrowheads). Besides threonine and serine,
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human sperm heat-treated extract was dephosphorylated
by treatment with protein tyrosine phosphatase 1B (PTP),
calf intestinal phosphatase (CIP) and PPP1CC1. Under the
conditions used, only CIP, a nonspecific phosphatase, could
dephosphorylate the PPP1R2 and PPP1R2P3, with an in-
crease in electrophoretic mobility. This band however did
not run at the same molecular mass as recombinant
PPP1R2 (Figure 8C). When sperm PPP1R2 was incubated
with GSK3 or CK2 or both, only GSK3 was able to induce
a mobility shift (Figure 8D).
Conclusions
The data here presented clearly shows that PPP1R2 is
present in human sperm, based on immunoreactivity
and mass spectrometry analysis. This supports the
model that the PPP1 inhibitor activity identified several
years ago can be accounted for by PPP1R2 [3,5]. In the
past, PPP1R2 mRNAs of 1.2 kb, 1.4–1.7 kb, 2.4–2.7 kb
and 4 kb have been found in rat and rabbit testis [28].
These mRNAs strictly correspond to the polyadenylation
(polyA) signals present in PPP1R2. Further, a new highly
expressed testis-specific 0.9–1.1 kb message, presumably
spliced from the PPP1R2 gene was also found in rabbitFigure 8 Western blot analysis of endogenous PPP1R2/PPP1R2P3 from
PPP1R2/PPP1R2P3, with recombinant PPP1R2 and PPP1R2P3, using sheep a
(both PPP1R2 and PPP1R2P3). Recombinant PPP1R2P3 and PPP1R2 are sho
of hsPPP1R2 human sperm extract. Left panel, heat-stable human sperm ex
with recombinant PPP1R2. Arrowheads indicate the three spots with differe
presence of different phosphatases, in the respective buffers at 30ºC for 3 h
Phosphatase 1B; CIP, incubation with Calf Intestinal Phosphatase; PPP1, incu
control. (D), hsPPP1R2 was incubated in the presence of GSK3 (G) or CK2 (C
migration, probably reflecting alterations in phosphorylation, were detectedand rat. This message only was detected after 50 days
and not before 20 days of age in rats [28,37]. Another
report identified PPP1R2 protein in heat-stable extracts
of bull testis and mouse testis and sperm [35]. Of
particular relevance we identified, by mass spectrometry,
a second PPP1R2-related protein in human sperm,
termed PPP1R2P3. This was previously considered to be
a pseudogene because it lacks introns, has no parental
promoter, and seems to be integrated in the genome at a
random new location. Pseudogenes originate from
retrotransposition activity, so they have truncated 5’UTR
due to the low processivity of the reverse transcriptase,
and direct repeats at both ends [38]. Testis is an organ
where many pseudogenes are expressed as mRNA and
proteins that have been shown to actively participate in
spermatogenesis or other germ cell functions [39,40].
Transcription in testis, when compared to other somatic
tissues, tends to activate alternative promoters, which
are otherwise imperfect or weak [40,41]. The apparent
function of pseudogenes in testis germ cells could be a
way to facilitate the appearance of new genes from the
parental ones [39].
Previous work suggests that PPP1CC2 plays a key role
in sperm motility. This enzyme is likely regulated by ahuman sperm. (A), Comparison of endogenous human sperm
nti-PPP1R2 antibody. hsPPP1R2, heat-stable human sperm extract
wn as positive controls. (B), Anti-PPP1R2 Western blot of 2D separation
tract; right panel, heat-stable human sperm extract supplemented
nt molecular mass and pI (C), hsPPP1R2 was incubated in the
rs. 0, no phosphatase, control; PTP, incubation with Protein Tyrosine
bation with PPP1CC1. Recombinant PPP1R2 is shown as a positive
), or both (G/C), as previously described. Resulting changes in protein
by Western blot analysis using the sheep anti-PPP1R2 antibody.
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PPP1R2 mediated by GSK3 kinase [3,5]. Peptides for
PPP1CC2 were recovered in immunoprecipitates of
PPP1R2/PPP1R2P3, indicating the presence of complexes
between the enzyme and the inhibitors in sperm. Since
immunoprecipitation was through antibodies against
PPP1R2 the presence of other regulatory subunits were
not determined. However, the results support the view
that at least a proportion of PPP1 in sperm is likely to be
regulated by PPP1R2 proteins. Our results also show that
PPP1R2P3 is phosphorylated by CK2 in vitro, probably at
residues 121, 122 or 127, as shown by the MS-MS spectra,
even though the Ser87 is absent. Peptides previously
assigned to PPP1R2P3 protein may have been derived also
from PPP1R2 [42,43]. Acetylation at Ala2 and phosphoryl-
ation at Ser121 and Ser122 were observed by high
throughput shotgun MS analysis in human Jurkat T cell
leukemia and embryonic kidney (HEK293) cell lines
[42,43]. These regions (Ala2, Ser121 and Ser122) are simi-
lar in both PPP1R2 and PPP1R2P3.
PPP1R2 interaction with PPP1C involves two primary
motifs, 145KLHY148 and 43KSQKW47. Other points of
contact in PPP1R2 are the N-terminal SILK motif
(12KGILK16, in humans) that possibly initiates the
binding, and the C-terminal acidic stretch, required for
the PPP1 activation by GSK3 [28,44,45]. We show for
the first time that PPP1R2P3 has all the PPP1 binding
motifs, but lacks the key phosphorylation sites Thr73
and Ser87. These results are consistent with a model
whereby PPP1R2P3 forms a complex with PPP1C but
the activity of this complex would not be regulated by
GSK3. The data show that PPP1R2P3 protein binds
directly to PPP1CC and that this inhibitor cannot be
phosphorylated by GSK3. The presence of this protein
variant, which may be an irreversible inhibitor of
PPP1CC provides for a novel mode of regulating the
catalytic activity of the phosphatase (Figure 4).
Intrasperm localization analysis showed that both
PPP1R2/PPP1R2P3 and PPP1CC2 co-localize in the
same sperm subcellular structures. That is, PPP1CC2 is
probably bound to the axoneme along with PPP1R2/
PPP1R2P3 (Figures 5, 6 and 7). A previous report
showed that PPP1 in Chlamydomonas is anchored to the
central pair apparatus of the axoneme, associated with
the C1 microtubule and to a lesser extent to the outer
doublet microtubules. This axonemal localization sug-
gests that PPP1 can control both dynein arms and
thereby kinetic activity of the flagellum [46]. Moreover,
PPP1C has a two-fold higher activity in immotile bovine
caput epididymal sperm compared to mature motile
caudal sperm which is consistent with it being directly
involved in sperm motility [3,5]. The regulation of sperm
motility by this phosphatase should involve its inhibitors.
We hypothesize that in the initial segments of theepididymis (caput) sperm are immotile due to the re-
versible activity of the PPP1R2/PPP1CC2 complexes,
while in the latter segments of the epididymis (cauda),
PPP1R2P3 substitutes for PPP1R2 as an irreversible
inhibitor of PPP1CC2 thereby resulting in sperm motil-
ity. These independent interactions may be occurring
concurrently, since peptides specific for both proteins
were identified in ejaculated sperm. Since sperm are
terminally differentiated cells, essentially devoid of tran-
scriptional and translational activity, regulation occurs
through pre-existing proteins and not through new syn-
thesis of proteins. It is possible that PPP1R2P3 could be
bound to another protein that may keep it from binding
to PPP1CC2 in immotile caput sperm, in a similar man-
ner to what is suggested to occur with sds22 (PPP1R7)
in caput sperm [47]. Also, other PPP1CC2 complexes
exist in sperm as dimers or trimers: such as PPP1R11/
PPP1R7/PPP1CC2 [6,22].
This mechanism of controlling sperm motility by
PPP1CC2 and GSK3 may operate only in mammals,
since other vertebrate classes do not have this alterna-
tively spliced phosphatase [33]. Furthermore, PPP1R2P3
protein, which is only present in primates, could lead to
a novel regulatory mechanism for regulating PPP1CC2
activity that might have evolved only in this order.
Determination of the validity of these possibilities needs
further studies. Work is in progress in our laboratory
to determine the mechanistic role of PPP1R2 and
PPP1R2P3 in regulating PPP1CC2 activity and thereby
motility and fertility of spermatozoa.
Methods
Yeast two-hybrid
Methods for yeast two-hybrid screening of a human
testis cDNA library using human PPP1CC have been
previously described [15,48,49]. DNA sequence analysis
was performed using an ABI PRISM 310 Genetic Ana-
lyser (Portugal Applied Biosystems, Porto, Portugal).
The DNA sequences obtained were compared to the
NCBI database, using the BLAST algorithm (http://
BLAST.ncbi.nlm.nih.gov/). The multiple sequence align-
ments were performed using the ClustalW program
from Ensembl.
PPP1R2 and PPP1R2P3 cloning, expression and
purification
The cDNA of PPP1R2P3 was ligated into the pET28c
(Novagen, Madison, Wisconsin, USA) expression vector
using EcoRI and XhoI restriction sites, adding a histidine
tag (His-tag) to the N-terminus of the protein. The pET-
PPP1R2P3 sequence was verified and the plasmid
transformed into E. coli strain Rosetta (DE3) (Novagen,
Madison, Wisconsin, USA). The expression of His-tag
PPP1R2P3 was induced with 1 mM isopropyl β-D-1-
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the protein purified using a Ni-NTA resin (QIAGEN,
Dusseldorf, Germany) according to the supplier’s in-
structions. Briefly, the cells were lysed in 10 mM imid-
azole, sodium phosphate buffer, pH 8.0, centrifuged at
15000 g for 30 min at 4ºC, and the supernatant was
applied to the resin. The resin was washed with
20 mM imidazole and the His-tag PPP1R2P3 was
eluted with 500 mM imidazole. The protein was
further purified by 12% SDS-PAGE. A portion of the
lane containing PPP1R2P3 was stained with Coomassie
blue and the region containing the remaining protein
was excised, washed three times with water, cut into
smaller pieces and 1 ml of 100 mM Tris-HCl, pH 8.5,
0.1% SDS was added before freezing at -20ºC over-
night. The slurry was frozen and thawed three times
and then passed through a 0.22 μm filter membrane.
The gel-free filtrate was then dialyzed against 4 ×
500 ml of 10 mM Tris-HCl, pH 7.5 buffer for 24 hrs
at 4ºC. The protein concentration of recombinant
His-PPP1R2P3 was determined by BCAW assay (Fisher
Scientific, Loures, Portugal). PPP1R2P3 cDNA was also
ligated into the pTACTAC expression vector [50] in
the NdeI and XbaI restriction sites, the sequence veri-
fied and then transformed into Rosetta strain. The ex-
pression of PPP1R2P3 was induced with 0.4 mM
IPTG for 3 hrs at 37ºC. The protein was partially
purified by boiling the bacterial extract (here on re-
ferred to as recombinant PPP1R2P3) as previously de-
scribed for PPP1R2 [25]. PPP1R2 cDNA was likewise
ligated in pTACTAC expression vector [50] and
recombinant protein purified in the same way as for
PPP1R2P3 (here on referred to as recombinant
PPP1R2). PPP1R2P3 cDNA was excised using EcoRI and
XhoI from pET-PPP1R2P3 and subcloned in pACT-2
vector (Clontech, Saint Germain-en-Laye, France) for
co-transformation.
Yeast co-transformation with plasmid DNA
Yeast competent AH109 cells were co-transformed with
pACT-PPP1R2P3 and pAS2-PPP1CA, pAS2-PPP1CC1,
pAS2-PPP1CC2 or pAS2-PPP1CC2end, by the lithium
acetate method [15]. pAS2-PPP1CC constructs used
were previously described [15]. For negative and positive
controls pAS2-1/pACT-2 and pVA3-1/pTD1-1 vectors
were used, respectively. Afterwards, the transformation
mixture was plated on selective media containing X-
.alpha;-Gal and incubated at 30ºC to check for MEL1 ex-
pression as indicated by the appearance of a blue color
(Clontech, Saint Germain-en-Laye, France).
Blot overlay analysis
For blot overlay analysis, 0.3 μg of commercial PPP1R2
(NEB, New England Biolabs, Herts, UK) and recombinantHis-PPP1R2P3 were resolved by SDS-PAGE and then
transferred to a nitrocellulose membrane. Blots were over-
laid with purified PPP1CC1 or PPP1CC2 (25 pmol/mL) di-
luted in Tris buffered saline with Tween-20/BSA [48,51]
and detected with the antibodies CBC3C (against the C-
terminal of PPP1CC, which detects both isoforms [52]) or
CBC502 (specific for the C-terminal of PPP1CC2), both
raised in rabbit. Immunoreactive bands were revealed by
incubating with horseradish peroxidase conjugated anti-
rabbit secondary antibody and developed by enhanced
chemiluminescence (ECL, GE Healthcare, Amersham
Biosciences Europe GmbH, Freiburg, Germany).
Phosphatase activity assays
The IC50 values of PPP1R2 and PPP1R2P3 for purified
PPP1CC1 and PPP1CC2 isoforms were determined
using [32P]phosphorylase a as substrate. The substrate
was prepared from phosphorylase b (Sigma-Aldrich
Química, S.A., Sintra, Portugal) using [γ-32P]ATP
(3000 Ci/mmol, GE Healthcare, Amersham Biosciences
Europe GmbH, Freiburg, Germany) and phosphorylase
kinase (Sigma-Aldrich Química, S.A., Sintra, Portugal) as
previously described [48]. An appropriate range of con-
centrations of commercial PPP1R2 and His-PPP1R2P3
were incubated with the purified PPP1C isoforms and
the phosphatase activity determined. The IC50 was
calculated using the BioDataFit 1.02 software (Chang
Bioscience, Castro Valley, California, USA).
Sperm extracts
Ejaculated sperm were collected from healthy donors by
masturbation into an appropriate sterile container.
Spermograms were performed by experienced techni-
cians and only samples with normal parameters were
used [53]. For all the methods, sperm was washed three
times in 1× PBS. For immunoprecipitation, sperm was
lysed in 1× RIPA buffer (radioimmunoprecipitation buf-
fer, Millipore Iberica S.A.U., Madrid, Spain) supplemented
with protease (10 mM benzamidine, 1.5 μM aprotinin,
5 μM pepstatin A, 2 μM leupeptin, 1 mM PMSF) and
phosphatase (1 mM sodium fluoride, 2.5 mM sodium pyro-
phosphate, 50 mM beta-glycerophosphate, 1 mM sodium
orthovanadate) inhibitors, sonicated 3× for 10 sec and
centrifuged at 16000 g for 20 min, at 4ºC. The supernatant
was collected and heat-stable extracts were prepared by im-
mersing the sample in a boiling water bath for 30 min,
chilled on ice for 2 min and centrifuged at 16000 g for
20 min, at 4ºC. The final supernatant was used in the sub-
sequent steps. For Western blot, both the supernatant
(soluble fraction) and the pellet (insoluble fraction) were
resuspended in 1% SDS [54].
For the preparation of heads and tails, washed sperm
were briefly sonicated and the detachment checked by
phase contrast microscopy (PH) using an Olympus IX81
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software (Olympus Portugal - Opto-Digital Tecnologias,
S.A., Lisboa, Portugal). Sperm were directly applied onto
a sucrose step gradient (1.8 M, 2.02 M and 2.2 M) to
separate heads from tails, by centrifuging at 5000 g for
1 hr and fractions corresponding to tails and heads col-
lected. Subsequently fractions were centrifuged at
16000 g, 10 min, resulting in a pellet free of sucrose and
proteins were dissolved in 1% SDS. For immunocyto-
chemistry, washed sperm was used directly on the cover-
slips. Human testicular biopsy was also prepared using
1% SDS and the same protocol as for sperm samples,
but previously homogenized using a tissue homogenizer.
Testicular biopsy was collected in Centro Hospitalar de
Coimbra, Portugal during a procedure to collect organs
for transplantation from a brain death 35-years-old adult
man and the biopsy was diagnosed as “normal spermato-
genesis” based on histopathological analysis.
Consent
Written informed consent, for the use of sperm samples,
was obtained from the donors for publication and any
accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this jour-
nal. The study was conducted in accordance with the
guidelines of the “Helsinki Declaration”.
Testicular biopsies for research purposes are covered
by the legislation of the Portuguese Constitution (decreto-
lei nº274/99 of July 22, 1999: “It is permitted the dissection
of corpses, or parts of them, of national citizens, stateless
persons and foreign residents in Portugal, as well as extrac-
tion of parts, tissues or organs when the deceased has expli-
citly declared in life's will that his body can be used for
purposes of teaching and scientific research.”).
Phosphorylation of PPP1R2 and PPP1R2P3
Recombinant PPP1R2, PPP1R2P3 or human sperm heat
extract of native PPP1R2/PPP1R2P3 (about 200 ηg of
inhibitor protein in 50 mM Tris-HCl pH 7.5, 0.1 mM
EGTA and 0.03% Brij-35) were phosphorylated by
GSK3β or CK2 (Calbiochem, MERCK, Darmstadt,
Germany) or both kinases as previously described [28].
The phosphorylation reaction was run at 30ºC for
90 min and then terminated with the addition of 4× SDS
loading buffer. Two separate 12% gels were run, one
with 1/10 of the reaction volume and the other
with the remaining 9/10 of the reaction volume. The
1/10 reaction gel was transferred and analyzed by
Western blot while the 9/10 reaction gel was dried
and autoradiographed.
Immunoprecipitation
RIPA supernatant sperm extracts were pre-cleared using
dynabeads protein G (Life Technologies S.A., Madrid,Spain). A direct immunoprecipitation approach was
performed with 1 μg of sheep anti-PPP1R2 or rabbit
anti-PPP1R2 pre-incubated with DynabeadsW Protein G
during 1 hr at 4ºC with rotation. After incubation,
pre-cleared sperm extracts were applied to the antibody-
dynabeads complex and incubated overnight with
rotation at 4ºC. After washing three times with 1× PBS
in 3% BSA for 10 min with rotation at 4ºC, beads were
resuspended in loading buffer and boiled.
Mass spectrometry
For mass spectrometry analysis, immunoprecipitates
were resolved by 10% SDS-PAGE along with purified
positive controls. Gels were stained with Coomassie blue
colloidal (Sigma-Aldrich Química, S.A., Sintra, Portugal).
In brief, gels were fixed with a fixation solution (40%
methanol and 10% acetic acid) during 1 hr, washed with
distilled water and then transferred to the Coomassie
blue colloidal staining solution for 1 hr. After staining,
the gels were washed with distilled water and afterwards
destained with 25% methanol until bands were visualized.
Bands were excised directly from the gel using a
spatula and completely destained. In-gel digestion was
performed overnight at 37°C with trypsin (Promega,
Madison, Wisconsin, USA) in 10 mM HCl and 50 mM
ammonium hydrogen carbonate (NH4HCO3) at pH 7.8.
Resulting peptides were extracted once with 100 μl of
1% formic acid (FA), and twice with 100 μl of 5% FA,
50% acetonitrile (ACN). Extracts were combined and
ACN was removed in vacuo. For LC-MS analysis, a final
volume of 40 μl was prepared by addition of 1% FA.
Electrospray tandem mass spectrometry (ESI-MS/MS)
was performed on an Orbitrap Velos instrument (Thermo
Scientific, Bremen, Germany). Fragment ions were gener-
ated by low-energy collision-induced dissociation (CID) on
isolated ions with a fragmentation amplitude of 0.5 V. MS
spectra were summed from four individual scans ranging
from m/z 300–1500 with a scanning speed of 8.100 (m/z)/s.
MS/MS spectra were a sum of two scans ranging from m/z
100–2800 at a scan rate of 26.000 (m/z)/s. Generated data
were imported to ProteinScape™, a proteomics data plat-
form (Bruker Daltonik GmbH, Bremen, Germany) and ana-
lyzed using MASCOT (version 2.2.0, Matrix Science,
London, UK) search algorithm with search parameters as
follows: precursor ion tolerance of 1.2 and 0.3 Da for MS/
MS spectra. Proteins were considered to be identified if the
Mascot score (ProteinScape™) was higher than 65.Western blotting
Extracts were mass normalized using BCAW assay (Fisher
Scientific, Loures, Portugal). Immunoprecipitates and ex-
tracts were resolved by 10% SDS-PAGE. Proteins were sub-
sequently electrotransferred onto nitrocellulose membranes
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ECL detection (GE Healthcare Spain, Madrid, Spain). The
primary antibodies used in this study included sheep poly-
clonal anti-PPP1R2 (1:100), the rabbit CBC502 (1:2000,
against the C-terminal of PPP1CC2), the rabbit CBC3C
(1:1000, against the C-terminal and detects both PPP1CC
isoforms) and the loading controls, mouse monoclonal anti-
β-tubulin (1:500, Life Technologies S.A., Madrid, Spain) and
mouse monoclonal acetylated-α-tubulin (1:2000, Life Tech-
nologies S.A., Madrid, Spain). The secondary antibodies
used were horseradish peroxidase-conjugated anti-rabbit
(1:5000), anti-sheep (1:1000) and anti-mouse (1:5000) IgGs
for ECL detection (GE Healthcare, Amersham Biosciences
Europe GmbH, Freiburg, Germany).Immunocytochemistry
An aliquot of washed diluted sperm (25 μl) was placed onto
a glass coverslip pre-coated with 100 μg/ml poly-L-orni-
thine, and dried at room temperature, in a six-well plate
containing one coverslip per well. To each well 1 ml of 4%
paraformaldehyde in 1× PBS was gently added and left to
stand for 10 min. Subsequently, sperm sample was washed
twice with 1 ml 1× PBS for 10 min. For permeabilization,
1 ml of 1:1 methanol/acetone solution was added for 2 min
and then the samples washed twice with 1 ml 1× PBS for
10 min and blocked for 1 hr with 3% BSA in 1× PBS, before
incubation with primary antibodies (rabbit CBC502, 1:250
and sheep anti-PPP1R2, 1:100) for 2 hrs at room
temperature. After three washes with 1× PBS, the fluores-
cently labeled secondary antibodies anti-rabbit Texas-Red,
1:300 (MolecularProbes, Eugene, USA) and anti-sheep
FITC, 1:50 (DAKO, Glostrup, Denmark) were added and
the coverslips incubated for 2 hrs. Finally, three washes
with 1× PBS were performed and coverslips were mounted
on microscope glass slides with one drop of anti-fading
reagent containing DAPI for nucleic acid staining
(Vectashield, Vector Laboratories Burlingame, California,
USA). Images were acquired using an Olympus IX81 epi-
fluorescence microscope and digital camera, equipped with
the appropriate software (Olympus Portugal-Opto-Digital
Tecnologias, S.A., Lisboa, Portugal).2D-PAGE analysis
The human sperm heat-stable extracts (hsPPP1R2) or
hsPPP1R2 plus 10 ηg of recombinant PPP1R2 were
acetone precipitated and the pellets were resuspended in
250 μl of 2D rehydration solution (8 M Urea/ 2 M Thio-
urea/ 2% CHAPS/ 0.002% of bromophenol blue) and
supplemented with 2.5 μl of IPG buffer (in the 4–7 pH
range) and 14 mg of DTT. The samples were pipetted
into a strip holder and the electrophoresis was started
(1 hr at 30 V, 2 hrs at 150 V, 1 hr at 500 V, 1 hr at
1000 V and 2 hrs at 8000 V). After the seconddimension on 12% gels, samples were analyzed by
Western blot.
Dephosphorylation of human sperm PPP1R2/PPP1R2P3
The hsPPP1R2 extracts were incubated overnight with
either protein tyrosine phosphatase 1B (Upstate, Millipore
Iberica S.A.U., Madrid, Spain) at 37ºC, calf intestinal phos-
phatase (NEB, New England Biolabs (UK), Herts, UK) at
37ºC or PPP1CC1, at 30ºC, with the respective assay
buffers. The reactions were stopped with the addition of 4×
SDS loading buffer and analyzed by Western blot.
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